PharmaEssentia Balance Sheet Health
Financial Health criteria checks 5/6
PharmaEssentia has a total shareholder equity of NT$23.9B and total debt of NT$96.1M, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are NT$27.3B and NT$3.3B respectively.
Key information
0.4%
Debt to equity ratio
NT$96.07m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$19.67b |
| Equity | NT$23.95b |
| Total liabilities | NT$3.32b |
| Total assets | NT$27.27b |
Recent financial health updates
Recent updates
Is There An Opportunity With PharmaEssentia Corporation's (TWSE:6446) 25% Undervaluation?
Apr 02
Downgrade: Here's How Analysts See PharmaEssentia Corporation (GTSM:6446) Performing In The Near Term
Mar 18PharmaEssentia Corporation (GTSM:6446) Just Reported And Analysts Have Been Cutting Their Estimates
Mar 06Things Look Grim For PharmaEssentia Corporation (GTSM:6446) After Today's Downgrade
Mar 04PharmaEssentia (GTSM:6446) Is Using Debt Safely
Feb 10What Type Of Returns Would PharmaEssentia's(GTSM:6446) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Jan 06
PharmaEssentia Corporation's (GTSM:6446) Profit Outlook
Nov 30Financial Position Analysis
Short Term Liabilities: 6446's short term assets (NT$22.9B) exceed its short term liabilities (NT$2.2B).
Long Term Liabilities: 6446's short term assets (NT$22.9B) exceed its long term liabilities (NT$1.2B).
Debt to Equity History and Analysis
Debt Level: 6446 has more cash than its total debt.
Reducing Debt: 6446's debt to equity ratio has reduced from 4% to 0.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6446 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 6446 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.